|
|
|
|
Vol. 9, Issue 4, 853-863, April 1998
Department of Physiology and Biophysics, University of Texas Medical Branch, Galveston, Texas 77555-0641
Submitted August 1, 1997; Accepted January 14, 1998| |
ABSTRACT |
|---|
|
|
|---|
The membrane assembly of polytopic membrane proteins is a complicated process. Using Chinese hamster P-glycoprotein (Pgp) as a model protein, we investigated this process previously and found that Pgp expresses more than one topology. One of the variations occurs at the transmembrane (TM) domain including TM3 and TM4: TM4 inserts into membranes in an Nin-Cout rather than the predicted Nout-Cin orientation, and TM3 is in cytoplasm rather than the predicted Nin-Cout orientation in the membrane. It is possible that TM4 has a strong activity to initiate the Nin-Cout membrane insertion, leaving TM3 out of the membrane. Here, we tested this hypothesis by expressing TM3 and TM4 in isolated conditions. Our results show that TM3 of Pgp does not have de novo Nin-Cout membrane insertion activity whereas TM4 initiates the Nin-Cout membrane insertion regardless of the presence of TM3. In contrast, TM3 and TM4 of another polytopic membrane protein, cystic fibrosis transmembrane conductance regulator (CFTR), have a similar level of de novo Nin-Cout membrane insertion activity and TM4 of CFTR functions only as a stop-transfer sequence in the presence of TM3. Based on these findings, we propose that 1) the membrane insertion of TM3 and TM4 of Pgp does not follow the sequential model, which predicts that TM3 initiates Nin-Cout membrane insertion whereas TM4 stops the insertion event; and 2) "leaving one TM segment out of the membrane" may be an important folding mechanism for polytopic membrane proteins, and it is regulated by the Nin-Cout membrane insertion activities of the TM segments.
| |
INTRODUCTION |
|---|
|
|
|---|
ATP-binding cassette (ABC) membrane transporters
function as transport ATPases (for reviews see Higgins, 1992
; Doige and
Ames, 1993
; Childs and Ling, 1994
). Members of this family include
mammalian P-glycoprotein (Pgp) and cystic fibrosis transmembrane
conductance regulator (CFTR), yeast pheromone transporter (STE6), and
bacterial hemolysin transporter (Hly B) (Higgins, 1992
; Doige and Ames, 1993
; Childs and Ling, 1994
). They are polytopic membrane proteins with
multiple putative transmembrane segments (Higgins, 1992
).
The topological folding of Pgp, CFTR, and STE6 has been investigated.
Topologies different from the hydropathy prediction were found with Pgp
(Zhang and Ling, 1991
; Zhang et al., 1993
; Skach et
al., 1993
; Bibi and Béjà, 1994
; Zhang, 1996
) but not with CFTR (Chang et al., 1994
; Chen and Zhang, 1996
) or STE6
(Geller et al., 1996
). One of the alterations found in Pgp
topology is located in the region including transmembrane (TM)3 and TM4
(Zhang et al., 1993
, see Figure
1A). In the alternative folding of Pgp (Figure 1A, model II), TM4 inserts into membranes in an
Nin-Cout orientation opposite to the predicted
Nout-Cin orientation whereas TM3 is in
cytoplasm (Figure 1A, compare model I and II). On the other hand, TM3
and TM4 of CFTR insert in membranes in an orientation as expected
(Nin-Cout for TM3 and
Nout-Cin for TM4 as shown in model I of Figure
1A) (Chen and Zhang, 1996
).
|
The biogenesis of TM segments in an integral membrane protein is a
complicated process (for reviews see Walter and Johnson, 1994
; Corsi
and Schekman, 1996
; Rapoport et al., 1996
; Schatz and
Dobberstein, 1996
; Johnson, 1997
). A TM segment may function as an
uncleavable signal-anchor sequence to generate a class II orientation
(Nin-Cout) or as a stop-transfer sequence to
generate a class III orientation (Nout-Cin)
(von Heijne and Gavel, 1988
). For polytopic membrane proteins,
it has been proposed that the topology is generated by the sequential
membrane insertion of signal-anchor and stop-transfer sequences
(Blobel, 1980
; Wessels and Spiess, 1988
; Hartmann et al.,
1989
; Lipp et al., 1989
; Skach and Lingappa, 1993
). However,
recent studies with Pgp suggested that the membrane-insertion process
of each TM segment is more complicated than the prevailing sequential
insertion model (Zhang and Ling, 1991
; Skach et al., 1993
;
Zhang et al., 1993
, 1995
; Bibi and Béjà, 1994
).
Recently, polytopic membrane proteins which were forced to adopt
alternative topologies have been created both in bacteria (Gafvelin and
von Heijne, 1994
) and in mammalian cells (Gafvelin et al.,
1997
). In the alternative topologies of these proteins, one or more TM
segments were left out of the membrane to accommodate the proper
membrane orientation of other TM segments as observed with the
alternative topology of Pgp (see Figure 1A). Such a "leaving one
out" strategy may be an important mechanism for polytopic membrane
proteins to fold properly when topogenic signals from various TM
segments contradict each other. That is, some TM segments will be
forced to stay away from inserting into membranes in order for other TM
segments to insert into membranes properly.
To understand how the alternative topology of Pgp is formed and how the "leaving one out" strategy is regulated, we further dissected the topogenesis mechanism of Pgp in this study. We investigated in detail the membrane insertion properties of isolated TM3 and TM4 of both CFTR and Pgp in microsomal membranes. Our results suggest that TM4 of Pgp has a strong de novo activity for the Nin-Cout membrane insertion even in the presence of TM3 whereas TM3 does not have de novo activity to initiate Nin-Cout insertion. TM3 and TM4 of CFTR, on the other hand, have a similar level of de novo Nin-Cout membrane insertion activity, and TM4 functions only as a stop-transfer sequence when following TM3. Thus, Pgp can form an alternative topology whereas CFTR cannot.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials
pGEM-4z plasmid, SP6 and T7 RNA polymerase, RNase inhibitor (RNasin), ribonucleotides, RQ1 deoxyribonuclease, rabbit reticulocyte lysate (RRL), and dog pancreatic microsomal membranes (RM) were obtained from Promega (Madison, WI). [35S]methionine and Amplify were purchased from New England Nuclear (Boston, MA) and Amersham (Arlington Heights, IL), respectively. m7G(5')ppp(5')G cap analog was obtained from Pharmacia LKB Biotechnology (Piscataway, NJ). Peptide N-glycosidase F (PNGase F) and restriction enzymes were obtained from Boehringer Mannheim (Indianapolis, IN), New England Biolabs (Beverly, MA), or Promega. pCR cloning vector was obtained from Invitrogen (San Diego, CA). All other chemicals were obtained from Sigma Chemical (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA).
Engineering Recombinant DNA Constructs
Polymerase chain reaction (PCR) was used to make Pgp-TM3R and
Pgp-TM3,4R from pGPGP-N3 and pGPGP-N4 DNA templates (Zhang et al., 1993
) and CF-TM3R and CF-TM3,4R from CFTR-N3R and CFTR-N4R DNA templates (Chen and Zhang, 1996
), respectively. The first PCR was
primed with a common primer 5'-CACTTTTGCCAACCAG-3' (B50) in the
reporter domain and a second primer specific for each construct containing a Kozak translation initiation codon:
5'-GTGATGGAGTTTTTTCATGC-3' for Pgp-TM3R and Pgp-TM3,4R, and
5'-GAGACCATGCAGATGAGAATAG-3' for CF-TM3R and CF-TM3,4R. The PCR product
encoding TM3 or TM3-TM4 was cloned and propagated using a pCR cloning
vector (Invitrogen), released by EcoRI and BglII
digestion, isolated by gel electrophoresis, and finally ligated into a
vector containing a reporter cDNA linearized with EcoRI and
BglII. The reporter used in this study is the ATP-binding domain of Pgp, the same as used in our previous studies (Zhang et
al., 1993
; 1995
; Chen and Zhang, 1996
; and Zhang, 1996
).
To engineer Pgp-TM4R and CF-TM4R, TM4 in Pgp-TM3,4R and CF-TM3,4R was deleted by a two-step PCR. In the first PCR, we used B50 primer (see above) and an opposite primer that contains a sequence fused between the sequences outside the N- and C-terminal end of TM3. These primers were: 5'-GCCTCGAGTTTTGTCACCAATTCC-3' for Pgp-TM4R and 5'-GAGACCATGCAGATGAGAATAG-3' for CF-TM4R, respectively. The first PCR product was then used as a primer together with SP6 primer to amplify the remaining sequence of Pgp-TM3,4R and CF-TM3,4R, respectively. The second PCR product encoding TM4 was cloned using the pCR cloning vector and ligated to a reporter as described above.
Pgp-TM3R(S), Pgp-TM4R(S), and CF-TM4R(S) were engineered using PCR as described above using Pgp-TM3R, Pgp-TM4R, and CF-TM4R as templates, respectively. The sense primers were SP6 primer for Pgp-TM3R(S), 5'-TCGTGATGACTCGAGGCTGG-3' for Pgp-TM4R(S), and 5'-GAGACCATGGAGTTGTTACAG-3' for CF-TM4R(S). The antisense primers were 5'-GTCTGGTTTGGTTAGCTTC-3' for Pgp-TM3R(S), B50 primer (see above) for Pgp-TM4R(S), and 5'-CAAGATCTGAATCACAAGTCT-3' for CF-TM4R(S). The PCR product was cloned, propagated, and ligated to a reporter as described above.
A two-step PCR was used to engineer CF1,2-P3,4R construct. In the first
PCR, pGPGP-N4 (Zhang et al., 1993
) was used as a template to
amplify the sequence encoding TM3 and TM4 of Pgp. The primers used were
5'-GTCAAGCCGTGTTCTAGATAAAGAGCTCAACA-3' (the first 22 nucleotides are
from CFTR and the last 10 nucleotides are from Pgp) and B50 primer (see
above). The first PCR product was purified and used as a primer
together with the SP6 primer to amplify the sequence encoding the
N-terminal sequence including TM1 and TM2 of CFTR. The second PCR
product was digested with PstI and EcoRI, isolated, and then ligated into a vector containing the reporter-coding sequence and linearized with PstI and EcoRI.
To engineer CF1,2-P3R fusion protein, a PstI-XhoI
fragment from CF1,2-P3,4R DNA was released, isolated, and ligated into
pGEM-4z together with a XhoI-HindIII fragment
from pGPGP-N3 DNA (Zhang et al., 1993
). All DNAs were
sequenced to confirm the correct linkage and to eliminate any potential
mutations due to cDNA manipulation and PCR.
In Vitro Transcription and Translation
About 6 µg of recombinant DNA linearized with
HindIII was transcribed in the presence of 5 A260 U/ml cap analog m7G(5')ppp(5')G as
described previously (Zhang and Ling, 1991
). Removal of DNA templates
with RQ1 deoxyribonuclease after transcription and purification of RNA
transcripts was carried out according to Zhang and Ling (1991)
.
Cell-free translations in RRL, proteolysis/membrane protection assay,
limited endoglycosidase treatment, isolation of membrane fractions by
centrifugation, as well as analysis using SDS-PAGE and fluorography,
were performed as previously described (Zhang et al., 1993
).
| |
RESULTS |
|---|
|
|
|---|
De Novo Nin-Cout Insertion of Pgp TM4
We previously showed that in the folding that is different from
prediction (Figure 1A, model II), TM3 of Pgp is in cytoplasm and TM4 is
in the membrane in a Nin-Cout orientation
(Zhang et al., 1993
). In this study, we tested whether the
TM4 of Pgp has de novo signal sequence activity to initiate the
Nin-Cout membrane insertion. A fusion construct
encoding TM4 of Pgp followed by a glycosylation reporter was engineered
(Figure 1B, Pgp-TM4R). As shown in Figure
2A, translation of Pgp-TM4R in the
absence of microsomal membranes (RM) generated a 43-kDa protein (lane 1). In the presence of RM, an additional protein of 45-kDa was produced
(Figure 2A, lane 2). Separation of soluble and membrane-associated proteins by centrifugation revealed that all of the 45-kDa proteins and
about half of the 43-kDa protein were in the membrane pellet (Figure 2A, lanes 3 and 4). Endoglycosidase PNGase F treatment reduced
the 45-kDa protein to 43 kDa (Figure 2A, lanes 5 and 6), suggesting
that the 45-kDa protein is a glycosylated form of the 43-kDa protein.
Thus, the C-terminal reporter of the 45-kDa protein is likely in the RM
lumen (Figure 2C, Nin-Cout model).
|
To confirm lumenal location of the reporter peptide of the glycosylated
Pgp-TM4R protein, we performed proteinase K digestion of the membrane
fraction after translation. As shown in Figure 2B, a major peptide
fragment of 39 kDa was protected from digestion (lane 1). However,
digestion of membrane fractions permeabilized with Triton X-100 did not
generate this peptide (Figure 2B, lane 2), suggesting that generation
of the 39-kDa peptide fragment was due to the protection by the
membranes. The proteinase K-resistant 39-kDa peptide was reduced to
~37 kDa by PNGase F (Figure 2B, lane 3), suggesting that it was
glycosylated. Thus, the reporter of the glycosylated Pgp-TM4R protein
is located in the RM lumen. Taken together, we conclude that the TM4 of
Pgp has de novo activity to initiate Nin-Cout
membrane insertion. This activity may be important in generating the
alternative topology of Pgp (Zhang et al., 1993
).
De novo Nin-Cout Insertion of Pgp TM3
In the alternative topology of Pgp (Figure 1A), TM3 was located in cytoplasm. This suggests that TM3 did not initiate the Nin-Cout insertion in the presence of TM4. To determine the de novo insertion activity of TM3, we engineered a construct (Pgp-TM3R) similar to Pgp-TM4R (see Figure 1B). Translation of Pgp-TM3R in the absence of RM generated a protein of 42 kDa (Figure 3A, lane 1). In the presence of RM, no additional protein was produced (Figure 3A, lane 2). Separation of membrane fractions by centrifugation revealed that most of the 42-kDa protein was in the supernatant and only a small fraction of this protein was associated with membranes (Figure 3A, lanes 3 and 4). Thus, TM3 of Pgp does not have de novo activity to initiate Nin-Cout membrane insertion as compared with TM4 (compare lanes 3 and 4 in Figures 2A and 3A).
|
To determine whether the charged amino acids at the C-terminal side of
TM3 affect the de novo Nin-Cout membrane
insertion of TM3, we performed an experiment using a mutant Pgp-TM3R
that has two positive charges at the C-terminal side of TM3 mutated to
neutral and negative charges, respectively (see Figure 3C; see also
Zhang et al., 1995
). As shown in Figure 3A, separation of
membrane fractions by centrifugation (compare lanes 8 and 9) revealed
that the amount of membrane-associated mutant proteins was similar to
that of the wild-type protein (compare lanes 3-4 with lanes 8-9).
However, it should be noted that an additional protein of 44 kDa was
observed from the translation of the mutant Pgp-TM3R in the presence of
RM (Figure 3A, lane 7). This 44-kDa protein was reduced to 42 kDa by
endoglycosidase treatment (Figure 3A, lanes 9 and 10), suggesting that
it is glycosylated and likely has an Nin-Cout
orientation (Figure 3C). This is confirmed by proteinase K digestion of
the membrane-associated mutant Pgp-TM3R, which revealed that a
glycosylated 38-kDa protein was protected from digestion (Figure 3B,
lanes 4-6), whereas no detectable fragment was protected from the
wild-type protein (Figure 3B, lanes 1-3). These observations indicate
that alteration of positive charges at the C-terminal side of TM3
enhances the de novo Nin-Cout membrane insertion of TM3.
De Novo Nin-Cout Insertion of Pgp TM4 in the Presence of TM3
To determine the behavior of TM4 in the presence of its preceding TM3, we made a construct consisting of both TM3 and TM4 with a reporter (Figure 1B, Pgp-TM3,4R). As shown in Figure 4A, translation of Pgp-TM3,4R RNA generated a 44-kDa protein (lane 1). In the presence of RM, a protein of 46 kDa (indicated by an arrow) was also produced (Figure 4A, lane 2). After centrifugation, all of the 46-kDa protein was found in the membrane pellet (Figure 4A, lanes 3 and 4). Endoglycosidase treatment reduced this protein to 44 kDa (Figure 4A, lanes 5 and 6), suggesting that it is a glycosylated form of the 44-kDa protein. Thus, the reporter of Pgp-TM3,4R is located in RM lumen and glycosylated.
|
To determine whether the lumenal location of the reporter is due to the
Nin-Cout insertion of TM4, we performed
proteinase K digestion of membrane-associated Pgp-TM3,4R in comparison
with Pgp-TM4R. As shown in Figure 4B, a major 39-kDa peptide was
protected from digestion (indicated by an arrow in lane 2) which can be reduced to 37 kDa by endoglycosidase PNGase F (lane 3). The protected 39-kDa fragment has the same size as that protected from the Pgp-TM4R translation products (Figure 4B, compare lanes 2 and 3 with lanes 6 and
7). Thus, the glycosylated 46-kDa Pgp-TM3,4R translation product
represents the molecule with a Nin-Cout
orientation for TM4 (see Figure 4C). The above studies demonstrated
that the Pgp TM4 initiates a Nin-Cout insertion
into membranes even in the presence of its preceding TM3. Therefore,
TM4 has a strong de novo activity to initiate
Nin-Cout insertion and likely leaves TM3 in
cytoplasm. This is consistent with our previous observation that TM4
displays a Nin-Cout orientation in the presence
of its all preceding sequences (Zhang et al., 1993
).
De novo Nin-Cout Insertion of TM3 and TM4 of CFTR
Previously, we have shown that, unlike Pgp, CFTR expresses only
the predicted topology (Chen and Zhang, 1996
). It is interesting to
compare the membrane insertion properties of TM3 and TM4 of CFTR with
those of Pgp. To this end, we made CF-TM3R, CF-TM4R, and CF-TM3,4R
constructs (Figure 1C), similar to those of Pgp (Figure 1B).
Translations of these constructs are shown in Figure 5A. Both CF-TM3R and CF-TM4R produced
glycosylated proteins (Figure 5A, indicated by arrows in lanes 2 and 5)
in the presence of RM as compared with the reaction in the absence of
RM (Figure 5A, compare lanes 1 and 4 with lanes 2 and 5, respectively).
The glycosylation is confirmed by endoglycosidase treatment (Figure 5A,
lanes 3 and 6). However, translation of CF-TM3,4R in the presence of RM did not generate any glycosylated proteins (Figure 5A, lanes 8 and 9).
|
To confirm that the reporters in the glycosylated CF-TM3R and CF-TM4R proteins are located in the RM lumen, we treated the membrane-associated proteins with proteinase K. As shown in Figure 5B, proteinase K digestion of membrane-associated CF-TM3R and CF-TM4R resulted in peptide fragments of 33 kDa and 42 kDa, respectively (lanes 1 and 4). These peptides were sensitive to PNGase F treatment (Figure 5B, lanes 2 and 5), suggesting that they are glycosylated. Complete removal of these fragments in the presence of Triton X-100 suggests that they are located in the RM lumen. Proteinase K digestion of membrane-associated CF-TM3,4R, on the other hand, did not generate any membrane-protected fragments (Figure 5B, lanes 7-9), consistent with the observation that the reporter in CF-TM3,4R is not glycosylated. Thus, the reporter of CF-TM3,4R is likely located outside of RM.
To test further the de novo membrane insertion activity of TM3 and TM4 of CFTR, the translation of CF-TM3R and CF-TM4R in the presence of RM was separated by centrifugation. As shown in Figure 5C, TM3R and TM4R proteins are present in similar low levels in the membrane pellet. Thus, there is no significant difference between the de novo activity of TM3 and TM4 to initiate Nin-Cout membrane insertion.
Based on the above observations, we conclude that TM3 and TM4 of CFTR by itself can initiate a similar level of membrane insertion to adopt Nin-Cout orientation. However, unlike Pgp, the TM4 of CFTR does not initiate the Nin-Cout insertion in the presence of its preceding TM3. Therefore, CFTR cannot form the alternative topology (Figure 1A, model II).
De Novo Membrane Insertion of TM3 and TM4 with Shorter Flanking Domains
Previously, it has been shown that the cytoplasmic loops affect
the membrane insertion of TM segments (McGovern et al.,
1991
; Seligman and Manoil, 1994
). In the above studies with Pgp-TM4R and CF-TM4R proteins, a loop linking TM2 and TM3 was included at the
N-terminal side of TM4 in our TM4R constructs. To determine whether
this loop affects the membrane insertion property of TM4, we engineered
new constructs named Pgp-TM4R(S) and CF-TM4R(S) (see Figure
6A). In these constructs, only five to
seven amino acid residues from the short loop between TM3 and TM4 were
included at the N-terminal side of TM4. It has been shown that about 15 amino acids on each side of a TM is important for topogenesis (Hartmann
et al., 1989
). Thus, to avoid interrupting the integrity of
the TM4 topogenesis 19-21 amino acids were retained at the C-terminal
side of TM4 in these constructs. As shown in Figure 6B, translation of
Pgp-TM4R(S) in the presence of RM generated a protein of a similar size
with that in the absence of RM (Figure 6B, lanes 1 and 2). However,
more than half of the Pgp-TM4R(S) products translated in the presence
of RM were found in the membrane pellet (Figure 6B, lanes 3 and 4),
suggesting that the TM4 without the long loop at the N-terminal side
can still insert into membranes. When treated with PNGase F, the size
of all membrane-associated Pgp-TM4R(S) was reduced (Figure 6C, lanes 1 and 2), suggesting that the reporter of Pgp-TM4R(S) has been
translocated into the RM lumen and glycosylated. It should be noted
that the deglycosylated Pgp-TM4R(S) is smaller in size than that
translated in the absence of RM. This is likely due to the
translocation of the C-terminal reporter into the RM lumen and exposure
of a cryptic signal sequence cleavage site at the C-terminal side of
TM4 (Figure 6D, Pgp-TM4R(S)). The membrane-associated Pgp-TM4R(S) is
resistant to proteinase K treatment, confirming its location in the RM
lumen (Figure 6C, lanes 3 and 4). The fact that all membrane targeted
Pgp-TM4R(S) is glycosylated suggests that all membrane associated
Pgp-TM4R(S) has the Nin-Cout orientation.
Therefore, deletion of the domain at the N-terminal side of TM4 did not
reduce the de novo Nin-Cout membrane insertion
activity of TM4. However, the deletion revealed a cryptic signal
sequence cleavage site located at the C-terminal side of TM4.
|
Translation of CF-TM4R(S) in the presence of RM generated a glycosylated protein (Figure 6B, indicated by an arrow in lane 7) as shown by PNGase F treatment (Figure 6C, lanes 5 and 6). Proteinase K treatment showed that the glycosylated reporter is in the RM lumen (Figure 6C, lanes 7 and 8). Most of the unglycosylated CF-TM4R(S) were found in the supernatant (Figure 6B, lanes 7 and 8) as the CF-TM4R products. These results suggest that truncating the domains surrounding TM4 did not affect the Nin-Cout insertion of CFTR TM4 (Figure 6D).
In the studies of Pgp-TM3R shown in Figure 3, Pgp-TM3R contains four amino acids derived from TM4 at the C-terminal side of TM3. These amino acids may affect the membrane insertion property of TM3. To test this possibility, we made a new construct Pgp-TM3R(S) by deleting these four amino acids (see Figure 6A). Translation of Pgp-TM3R(S) did not generate a glycosylated molecule in the presence of RM (Figure 6B, lanes 9 and 10). Most of the Pgp-TM3R(S) products translated in the presence of RM were found in the supernatant and not associated with membranes (Figure 6B, lanes 11 and 12). The Pgp-TM3R(S) protein was not changed by PNGase F digestion, and no protected fragments were found when the membranes were treated with proteinase K (Figure 6C, lanes 9-12), confirming that the reporter of Pgp-TM3R(S) is not exposed to the RM lumen. Thus, removing the four residues of TM4 at the C-terminal side of TM3 did not increase the de novo Nin-Cout membrane insertion activity of Pgp TM3.
Effects of N-Terminal Membrane Anchorage Sequence on the Nin-Cout Insertion of Pgp TM4
The above studies suggested that TM4 of Pgp has a strong de novo
Nin-Cout insertion activity, which is
responsible for the generation of an alternative topology (Figure 1A,
model II). Previously, we have shown that the
Nin-Cout insertion of TM4 occurs even in the
presence of the N-terminal membrane-anchorage sequences TM1-TM2 (Zhang
et al., 1993
; 1995
). To determine whether the N-terminal membrane anchorage sequences affect the
Nin-Cout membrane insertion of TM4, we replaced
the N-terminal TM1-TM2 of Pgp by the homologous sequence from CFTR. The
newly created fusion protein was named CF1,2-P3,4R (Figure 1D). When
this fusion protein was translated in the presence of RM, to our
surprise, no glycosylated protein was generated (Figure
7A, lanes 1 and 4) although all of the
nascent proteins are associated with membranes (Figure 7A, lanes 2 and 3). Thus, the Nin-Cout insertion of TM4 in
CF1,2-P3,4R did not occur. On the other hand, the
Nin-Cout insertion of TM4 was generated in
Pgp-N4 with the native TM1-TM2. Using both limited endoglycosidase and
proteinase K digestion, we have previously shown that the protein
indicated by an arrow in lanes 5 and 7 of Figure 7A represents the
model II topology shown in Figure 1A (Zhang et al., 1993
). Thus, we conclude that the Nin-Cout insertion
by TM4 of Pgp is affected by the N-terminal membrane-anchorage
sequences (i.e., TM1-TM2). However, these sequences in Pgp permit TM4
to have the Nin-Cout insertion.
|
Effects of N-Terminal Membrane Anchorage Sequence on the Membrane Insertion of Pgp TM3
Although we have shown above that TM3 of Pgp does not have de novo
Nin-Cout membrane insertion activity, TM3 can
initiate Nin-Cout membrane insertion in a
molecule that is preanchored into membranes by TM1 and TM2 (Zhang
et al., 1993
). We have also shown above that the de novo
Nin-Cout insertion of TM4 can be affected by
the replacement of TM1 and TM2 from CFTR. It would be interesting to
know whether a similar replacement would affect the TM3 insertion. When
the N-terminal membrane anchorage sequences (TM1 and TM2) of Pgp were
replaced by the same sequence from CFTR, a glycosylated protein was
generated in the presence of RM (Figure 8A, indicated by an arrow in lanes 1 and
4), and it was associated with membranes (Figure 8A, lanes 2 and 3).
Proteinase K digestion of membrane-associated proteins also revealed a
membrane-protected and PNGase F-sensitive 38-kDa peptide fragment
(Figure 8B, lanes 1 and 2), confirming the lumenal location of a
glycosylated reporter. Thus, preanchorage of the nascent protein into
membranes by TM1 and TM2 from both CFTR and Pgp can help TM3 of Pgp
initiate an Nin-Cout membrane insertion. This
further suggests that TM3 and TM4 of Pgp have different membrane
insertion properties.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we investigated the de novo membrane insertion of TM3 and TM4 of hamster pgp1 Pgp in comparison with that of CFTR to elucidate the mechanism of generating alternative topologies of Pgp (model II, Figure 1A). We found that TM3 of Pgp does not have de novo activity to initiate Nin-Cout membrane insertion whereas TM4 of Pgp does. TM4 of Pgp can initiate an Nin-Cout membrane insertion even in the presence of its preceding TM3. However, unlike Pgp, TM4 of CFTR does not initiate an Nin-Cout membrane insertion in the presence of its preceding TM3. Based on this study and our previous findings, we conclude that 1) the membrane insertion of TM3 and TM4 of Pgp does not necessarily follow the sequential model, which predicts that TM3 initiates Nin-Cout insertion whereas TM4 stops the membrane translocation event and forms a Nout-Cin orientation; and 2) the "leaving one out" strategy may be universal for polytopic membrane proteins to fold properly when topogenic signals from various TM segments contradict each other (see below), and it is regulated by the Nin-Cout membrane insertion activities of the TM segments.
In this study, we also showed that the N-terminal membrane-anchorage
sequence including TM1 and TM2 of Pgp permits TM4 to have the
Nin-Cout insertion. Replacing the N-terminal
membrane-anchorage sequence with an equivalent one from CFTR abolished
this insertion. Apparently, the Nin-Cout
membrane insertion by TM4 of Pgp is not independent of the N-terminal
membrane anchorage sequences. It is only that the N-terminal membrane
anchorage sequences of Pgp allow TM4 to perform the
Nin-Cout membrane insertion. This is consistent
with our previous observation that the N-terminal sequence of human
MDR3 Pgp is important for the folding of internal TM segments (Zhang, 1996
).
Although we have shown that TM3 of Pgp does not have de novo
Nin-Cout membrane insertion activity, it can
initiate such an insertion if the protein is preanchored in the
membrane by its preceding sequence TM1 and TM2 from Pgp (Zhang et
al., 1993
) or from CFTR (this study). Thus, proteins with the
predicted topology (i.e., TM3 in Nin-Cout and
TM4 in Nout-Cin orientation) was also observed
in addition to the alternative topology when all four TM segments are
present (Zhang et al., 1993
). The de novo
Nin-Cout membrane insertion activity of TM3 can
also be increased by mutating the positively charged amino acids at the
C-terminal side of TM3 (see Figure 3). Hence, mutations of these
positively charged amino acid residues will increase the generation of
the predicted topology (i.e., TM3 in Nin-Cout
and TM4 in Nout-Cin orientation), consistent with our previous observation of mutation analysis (Zhang et
al., 1995
).
Using human MDR1 Pgp as a model protein, Skach and Lingappa
(1994)
showed that TM3 does not have de novo membrane insertion activity. A chimeric protein with TM3 and its following 19 amino acid
residues including 17 of 20 residues of TM4 can initiate a de novo
membrane insertion. These observations are consistent with this study.
However, they also showed that 1) TM4 does not have de novo
Nin-Cout membrane insertion activity and 2) TM3
alone cannot initiate membrane insertion in a molecule preanchored into membranes (Skach and Lingappa, 1994
). It is not known what caused the
discrepancy between the observations by Skach and Lingappa and our
studies. However, it may be due to 1) the sequence diversity between
human MDR1 Pgp used by Skach and Lingappa (1994)
and hamster pgp1 Pgp used in this study, 2) the different reporter
peptide sequence used (prolactin vs ATP-binding domain of Pgp), 3)
different fusion sites where the reporter gene was engineered (amino
acid 276 of human Pgp vs amino acid 249 of hamster Pgp for TM4), 4) different preanchorage sequences used for TM3 (IgM-derived
stop-transfer sequence vs TM1 and TM2 of Pgp), and/or 5) different
expression systems used (frog oocytes vs cell-free system). We are
currently investigating these possibilities.
In the alternative topology of Pgp, TM3 is likely located in the
cytoplasm when TM4 is inserted in membranes in an
Nin-Cout orientation. Such a "leaving one
out" strategy may be universal and possibly an important folding
mechanism when topogenic signals from various TM segments contradict
each other. For example, when both TM3 and TM4 of Pgp can initiate the
Nin-Cout insertion, only the one (TM4) with
stronger activity can adopt such an orientation and leaves the other
(TM3) out of the membrane. By increasing the
Nin-Cout insertion activity of TM3 (e.g.,
altering the charged amino acids at the C-terminal side of TM3) to
compete with TM4, more Nin-Cout insertion for
TM3 will be obtained, resulting in a decreased proportion of the
alternative topology (Zhang et al., 1995
). Recently,
polytopic membrane proteins that were forced to adopt alternative
topology by leaving one or more TM segments out of the membrane have
been created in both bacteria (Gafvelin and von Heijne, 1994
) and
mammalian cells (Gafvelin et al., 1997
).
Earlier studies on the biogenesis of polytopic membrane proteins
(Friedlander and Blobel, 1985
; Audigier et al., 1987
)
suggested that transmembrane segments in polytopic membrane proteins
have different functions as signal-anchor and stop-transfer sequences. Presumably, the first TM segment functions as a signal anchor sequence
whereas the second one functions as a stop-transfer sequence (Wessels
and Spiess, 1988
; Lipp et al., 1989
; Hartmann et
al., 1989
; Skach and Lingappa, 1993
). This membrane insertion
event by signal-anchor and stop-transfer sequences repeat itself until all TM segments are in the membrane. According to the sequential membrane insertion model, TM3 of Pgp initiates
Nin-Cout membrane insertion (signal-anchor)
whereas TM4 stops the membrane-translocation event (stop-transfer) and
forms a Nout-Cin orientation. However, our
studies indicated that TM4 is a strong signal-anchor sequence and
initiates the Nin-Cout insertion even in the
presence of TM3, resulting in the alternative topology. Both our
studies on Chinese hamster Pgp and the studies on bacterial leader
peptidase by von Heijne's group (Gafvelin and von Heijne, 1994
;
Gafvelin et al., 1997
) suggest that the sequential
signal-anchorage and stop-transfer model for membrane insertion of
polytopic membrane proteins is not applicable to every protein. Using
Pgp as a model protein, Borel and Simon (1996a
,b
) have shown that the
TM segments of Pgp do not integrate into lipid bilayer until the
protein is completely synthesized and released from the ribosome. While
the protein is being synthesized, the TM segments are likely
accumulating in the putative protein-conducting channel (Simon and
Blobel, 1991
). This observation may indicate an underlying mechanism
for the generation of alternative topologies of Pgp. Thus, we believe that Pgp is an ideal model protein for investigating membrane insertion
mechanisms of polytopic membrane proteins alternative to the prevailing
sequential membrane insertion mechanism.
It is believed that polytopic membrane proteins acquire their final
topology in ER membranes (Goldman and Blobel, 1981
; Braell and Lodish,
1982
; Brown and Simoni, 1984
; Wessels and Spiess, 1988
). Although
topologies alternative to the predicted one for Pgp were found using
cell-free frog oocytes and bacteria expression systems (Zhang and Ling,
1991
, Zhang et al., 1993
; Zhang, 1996
; Skach et
al., 1993
; Bibi and Béjà, 1994
), studies of mutant Pgp
by Loo and Clark (1995)
and Kast et al. (1995)
suggested
that Pgp has only the predicted topology on cell surface. Yet, using site-specific antibodies and wild-type Pgp in a multidrug-resistant cell line, we were able to show that the alternative topology of Pgp
exists on plasma membranes (Zhang et al., 1996
). It is currently unknown what the alternative topologies of Pgp mean to its
function. However, interchanges between different topological structures of Pgp may be involved in its transport function. Our recent
studies suggest that Pgp has a large conformational change during its
catalytic cycle, and this conformational change may represent the
putative topological conversion of Pgp (Wang et al., 1997
).
| |
ACKNOWLEDGMENTS |
|---|
We thank Dr. Ariel Castro for his critical comments on this manuscript and our colleagues at UTMB for their valuable suggestions during the course of this study. This work was supported by NIH grant CA-64539.
| |
FOOTNOTES |
|---|
* Corresponding author.
Abbreviations used: ABC, ATP-binding cassette; CFTR, cystic fibrosis transmembrane conductance regulator; MDR, multidrug resistance; PCR, polymerase chain reaction; Pgp, P-glycoprotein; RM, microsomal membranes; RRL, rabbit reticulocyte lysate; TM, transmembrane.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
W. Zhang, M. Bogdanov, J. Pi, A. J. Pittard, and W. Dowhan Reversible Topological Organization within a Polytopic Membrane Protein Is Governed by a Change in Membrane Phospholipid Composition J. Biol. Chem., December 12, 2003; 278(50): 50128 - 50135. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Joyce, G. S. Shelness, M. A. Davis, R. G. Lee, K. Skinner, R. A. Anderson, and L. L. Rudel ACAT1 and ACAT2 Membrane Topology Segregates a Serine Residue Essential for Activity to Opposite Sides of the Endoplasmic Reticulum Membrane Mol. Biol. Cell, November 1, 2000; 11(11): 3675 - 3687. [Abstract] [Full Text] |
||||
![]() |
M. van Geest and J. S. Lolkema Membrane Topology and Insertion of Membrane Proteins: Search for Topogenic Signals Microbiol. Mol. Biol. Rev., March 1, 2000; 64(1): 13 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Nilsson, S. Witt, H. Kiefer, I. Mingarro, and G. von Heijne Distant Downstream Sequence Determinants Can Control N-tail Translocation during Protein Insertion into the Endoplasmic Reticulum Membrane J. Biol. Chem., February 25, 2000; 275(9): 6207 - 6213. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, E Han, and Y Liu Role of the ribosome in sequence-specific regulation of membrane targeting and translocation of P-glycoprotein signal-anchor transmembrane segments J. Cell Sci., January 7, 2000; 113(14): 2545 - 2555. [Abstract] [PDF] |
||||
![]() |
K. Ota, M. Sakaguchi, N. Hamasaki, and K. Mihara Assessment of Topogenic Functions of Anticipated Transmembrane Segments of Human Band 3 J. Biol. Chem., October 23, 1998; 273(43): 28286 - 28291. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Foster, A. Helm, I. Turnbull, H. Gulati, B. Yang, A. S. Verkman, and W. R. Skach Identification of Sequence Determinants That Direct Different Intracellular Folding Pathways for Aquaporin-1 and Aquaporin-4 J. Biol. Chem., October 27, 2000; 275(44): 34157 - 34165. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||